Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160055/S055

RxSight Light Adjustable Lens; Light Delivery Device

Rxsight, Inc. · Decision date Jun 8, 2026

FDA DECISIONP160055/S055

What did the FDA approve?

FDA records P160055/S055 as a supplement to PMA P160055, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jun 8, 2026.

FDA approval order statement

approval for a change in the routine Ethylene Oxide sterilization process parameters, specifically a reduction in the Ethylene Oxide gas concentration used to terminally sterilize the subject devices
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Ophthalmic
Decision date
Jun 8, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P160055/S055
Regulatory pathway
PMA supplement
Applicant
Rxsight, Inc.
Product code
PZK
Decision code
APPR
Decision date
Jun 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light adjustable lens (LAL) and light delivery device (LDD).

Applicant
Rxsight, Inc.
Product code
PZK
FDA device class
3

For the original device and its historical approval scope, see PMA P160055. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160055 · Original PMA

    LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)

  2. P160055/S045 · Related supplement

    LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)

  3. P160055/S052 · Related supplement

    Light Adjustable Lens and Light Delivery Device

  4. P160055/S055 received

    Application receipt date recorded by FDA.

  5. P160055/S055 · FDA decision

    Real-Time Process

  6. P160055/S054 · Related supplement

    RxSight Light Adjustable Lens; Light Delivery Device

  7. P160055/S056 · Related supplement

    RxSight Light Adjustable Lens and Light Delivery Device

  8. P160055/S058 · Related supplement

    RxSight Light Adjustable Lens and Light Delivery Device

  9. P160055/S057 · Related supplement

    RxSight Light Adjustable Lens and Light Delivery Device

Timeline entries are records held by MedtechLedger for P160055. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160055

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rxsight, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
100 Columbia, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records